SCN1A Genetic Test for Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy and its Clinical Subtypes) for use in the Diagnosis, Prognosis, Treatment and Management of Dravet Syndrome

PLoS Currents

Volumn , Issue APR 2013, 2013, Pages

  Stenhouse, Susan A R ^a   Ellis, Rachael ^b   Zuberi, Sameer ^c  

^a UK Genetic Testing Network   (United Kingdom)

^b SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^c Royal Hospital for Sick Children   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; STIRIPENTOL; VALPROIC ACID;

ARTICLE; DIAGNOSTIC ERROR; DNA SEQUENCE; ELECTROENCEPHALOGRAM; GENE; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; LENNOX GASTAUT SYNDROME; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PHENOTYPE; PROGNOSIS; QUESTIONNAIRE; SCN1A GENE; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY;

EID: 84876920646     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.eogt.c553b83d745dd79bfb61eaf35e522b0b     Document Type: Article

References (5)

1. Jallon & Latour, 2005, Epilepsia, 46; 10-14.
2. Brunklaus et.al. 2012, Brain, 135; 2329-36.
3. Berkovic et.al. 2006, Lancet Neurol. 5; 488-92.
4. Brunklaus et.al. 2013, Dev.Med. & Child Neurol., 55; 154-161.
5. Catarino et. al. 2011, Brain, 134; 2982-3010.